Teachers Advisors’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$11.5M Buy
845,466
+88,560
+12% +$1.08M 0.01% 929
2018
Q4
$7.25M Buy
756,906
+720
+0.1% +$7.91K 0.01% 1102
2018
Q3
$9.14M Buy
756,186
+10,261
+1% +$143K 0.01% 1119
2018
Q2
$11.7M Buy
745,925
+22,377
+3% +$338K 0.01% 1016
2018
Q1
$10.9M Buy
723,548
+59,612
+9% +$907K 0.01% 996
2017
Q4
$9.55M Buy
663,936
+5,858
+0.9% +$80.5K 0.01% 1056
2017
Q3
$9.92M Buy
658,078
+396,533
+152% +$5.25M 0.01% 1028
2017
Q2
$2.63M Buy
261,545
+8,046
+3% +$64.7K ﹤0.01% 1660
2017
Q1
$1.81M Buy
253,499
+12,936
+5% +$81.8K ﹤0.01% 1827
2016
Q4
$1.2M Buy
240,563
+37,705
+19% +$261K ﹤0.01% 2085
2016
Q3
$1.5M Hold
202,858
﹤0.01% 1850
2016
Q2
$1.11M Buy
202,858
+29,564
+17% +$207K ﹤0.01% 1973
2016
Q1
$1.46M Buy
173,294
+1,750
+1% +$12.4K ﹤0.01% 1763
2015
Q4
$1.66M Buy
171,544
+3,348
+2% +$30.2K ﹤0.01% 1702
2015
Q3
$2.35M Buy
168,196
+27,694
+20% +$434K ﹤0.01% 1472
2015
Q2
$1.99M Buy
+140,502
New +$1.69M ﹤0.01% 1691
2014
Q2
Sell
-45,095
Closed -$93K 3152
2014
Q1
$93K Hold
45,095
﹤0.01% 3034
2013
Q4
$106K Hold
45,095
﹤0.01% 3021
2013
Q3
$105K Buy
45,095
+10,285
+30% +$25.8K ﹤0.01% 2997
2013
Q2
$81K Buy
+34,810
New +$107K ﹤0.01% 3012

Other funds holding FOLD

Teachers Advisors's FOLD Position: Q1 2019 in Review

Teachers Advisors increased its Amicus Therapeutics (FOLD) stake by 12% in Q1 2019, buying an estimated $1.08M and bringing the position to 845,466 shares worth $11.5M. The position accounts for 0.01% of the portfolio, ranked #929.

Teachers Advisors first reported a position in FOLD in Q2 2013 and has held it in 20 quarters since. The position peaked at $11.7M in Q2 2018. 205 funds tracked by Wall St. Rank hold FOLD as of Q1 2019.

  • Teachers Advisors held 845,466 shares of Amicus Therapeutics worth $11.5M as of Q1 2019.
  • Teachers Advisors bought 88,560 Amicus Therapeutics shares in Q1 2019, an estimated $1.08M.
  • Amicus Therapeutics made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #929 holding.
  • Teachers Advisors first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 20 quarters since.
  • Teachers Advisors's Amicus Therapeutics position peaked at $11.7M in Q2 2018.
  • 205 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.